Rigel Pharmaceuticals Inc (RIGL)
Net Receivables
$56.04M
Quarterly · Period ending: · USD
RIGL Net Receivables
Latest reported$56.04Mperiod ending
Latest reported$56.04Mperiod ending
RIGL Quarterly Net Receivables ($663.00K → $56.04M)
Quarterly net receivables
High-resolution chart · PNG
RIGL net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 56,041,000 | |
| 49,945,000 | |
| 51,763,000 | |
| 45,925,000 | |
| 39,907,000 | |
| 41,547,000 | |
| 41,615,000 | |
| 30,575,000 | |
| 28,904,000 | |
| 27,512,000 | |
| 30,550,000 | |
| 23,546,000 | |
| 20,819,000 | |
| 29,366,000 | |
| 40,320,000 | |
| 15,525,000 | |
| 17,198,000 | |
| 15,240,000 | |
| 15,472,000 | |
| 14,991,000 | |
| 17,372,000 | |
| 142,195,000 | |
| 15,973,000 | |
| 14,631,000 | |
| 11,727,000 | |
| 9,660,000 | |
| 10,111,000 | |
| 11,552,000 | |
| 6,933,000 | |
| 5,614,000 | |
| 4,077,000 | |
| 3,273,000 | |
| 1,620,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 95,000 | |
| 195,000 | |
| 203,000 | |
| 163,000 | |
| 350,000 | |
| 106,000 | |
| 5,750,000 | |
| 0 | |
| 0 | |
| 0 | |
| 5,750,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 25,000,000 | |
| 0 | |
| 100,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 299,000 | |
| 442,000 | |
| 294,000 | |
| 764,000 | |
| 1,400,000 | |
| 1,390,000 | |
| 1,752,000 | |
| 1,900,000 | |
| 2,541,000 | |
| 1,827,000 | |
| 1,620,000 | |
| 1,769,000 | |
| 2,532,000 | |
| 699,000 | |
| 873,000 | |
| 1,165,000 | |
| 1,031,000 | |
| 1,287,000 | |
| 1,769,000 | |
| 717,000 | |
| 1,575,000 | |
| 7,678,000 | |
| 107,000 | |
| 1,763,000 | |
| 2,529,000 | |
| 1,153,000 | |
| 3,676,000 |